Q/C Technologies, Inc. (QCLS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 3.57M USD | Liabilities, Current |
| Cash and equivalents | 307.61K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 10.68M USD | Marketable Securities, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.57M | $307.61K | $10.68M | (m) | (m) | (m) |
| 2026-03-31 | (m) | $3.69M | $1.13M | $11.85M | (m) | (m) | (m) |
| 2025-12-31 | (m) | $5.53M | $987.00K | $14.80M | (m) | (m) | (m) |
| 2025-09-30 | (m) | $6.53M | (m) | $3.09M | (m) | (m) | (m) |
| 2025-06-30 | (m) | $5.55M | (m) | $3.61M | (m) | (m) | (m) |
| 2025-03-31 | (m) | $4.94M | $73.24K | $5.81M | (m) | (m) | (m) |
| 2024-12-31 | (m) | $6.70M | $173.15K | $8.35M | (m) | (m) | (m) |
| 2024-09-30 | (m) | $6.99M | $1.19M | $9.45M | (m) | (m) | (m) |
| 2024-06-30 | (m) | $5.78M | $536.03K | $12.53M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $3.97M | $225.66K | $1.51M | (m) | (m) | (m) |
| 2023-12-31 | (m) | $4.99M | $2.68M | $2.24M | (m) | (m) | (m) |
| 2023-09-30 | (m) | $5.70M | $298.32K | $8.17M | (m) | (m) | (m) |
| 2023-06-30 | (m) | $2.43M | $93.82K | $11.53M | (m) | (m) | (m) |
| 2023-03-31 | (m) | $1.63M | $188.55K | $15.36M | (m) | (m) | (m) |
| 2022-12-31 | (m) | $2.77M | $749.09K | $4.09M | (m) | (m) | (m) |
| 2022-09-30 | (m) | $1.78M | $309.93K | $6.77M | (m) | (m) | (m) |
| 2022-06-30 | (m) | $2.90M | $1.12M | $4.51M | (m) | (m) | (m) |
| 2022-03-31 | (m) | $2.47M | $1.19M | $8.00M | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.04M | $555.97K | $11.00M | (m) | (m) | (m) |
| 2021-09-30 | (m) | $2.09M | $1.38M | $14.00M | (m) | (m) | (m) |
| 2021-06-30 | (m) | $3.35M | $2.13M | $19.50M | (m) | (m) | (m) |
| 2021-03-31 | (m) | $2.37M | $569.37K | $30.48M | (m) | (m) | (m) |
| 2020-12-31 | (m) | $2.26M | $18.62M | $16.72M | (m) | $197.72K | (m) |
| 2020-09-30 | (m) | $2.56M | $16.19M | $6.93M | (m) | (m) | (m) |
| 2020-06-30 | $18.31M | $2.71M | $11.45M | $6.86M | $2.30K | (m) | 6.77× |
| 2020-03-31 | $7.76M | $2.18M | $812.44K | $6.63M | $321.63K | $193.44K | 3.56× |
| 2019-12-31 | $9.72M | $1.53M | $517.44K | $9.16M | $42.88K | $198.99K | 6.36× |
| 2019-09-30 | $3.44M | $1.37M | $363.29K | $2.85M | $230.90K | $412.06K | 2.51× |
| 2019-06-30 | $4.54M | (m) | $248.44K | $4.02M | $266.86K | $544.24K | (m) |
| 2019-03-31 | $5.08M | (m) | $275.52K | $4.48M | $324.52K | $601.30K | (m) |
| 2018-12-31 | $5.63M | (m) | $181.75K | $5.27M | $176.33K | $585.27K | (m) |
| 2018-09-30 | $6.45M | $2.30M | $1.30M | $4.87M | $283.23K | $807.98K | 2.80× |
| 2018-06-30 | $8.67M | $1.85M | $275.96K | $7.98M | $412.62K | $1.01M | 4.68× |
| 2018-03-31 | $9.74M | $1.38M | $647.27K | $8.68M | $416.90K | $973.95K | 7.06× |
| 2017-12-31 | $6.94M | $1.77M | $438.43K | $5.01M | $1.49M | $1.85M | 3.91× |
| 2017-09-30 | $1.27M | $1.58M | $135.13K | $10.18K | $1.13M | $2.09M | 0.80× |
| 2017-06-30 | $2.14M | $1.45M | $197.18K | $1.01M | $927.53K | $2.17M | 1.48× |
| 2017-03-31 | $2.76M | $1.36M | $2.09M | $157.47K | $517.06K | $2.17M | 2.03× |
| 2016-12-31 | $723.97K | $1.70M | $72.70K | $50.00K | $601.27K | $2.04M | 0.43× |
| 2016-09-30 | $1.53M | $1.31M | $195.86K | $599.94K | $738.16K | $1.94M | 1.17× |
| 2016-06-30 | $2.47M | $1.57M | $379.53K | $1.55M | $542.52K | $1.22M | 1.58× |
| 2016-03-31 | $3.40M | $1.54M | $180.39K | $2.44M | $781.70K | $1.21M | 2.21× |
| 2015-12-31 | $5.04M | $1.67M | $402.06K | $4.03M | $609.20K | $1.13M | 3.02× |
| 2015-09-30 | $6.73M | $1.26M | $393.37K | $5.23M | $1.11M | $955.16K | 5.36× |
| 2015-06-30 | $8.58M | $1.16M | $261.23K | $6.42M | $1.90M | $821.99K | 7.36× |
| 2015-03-31 | $9.53M | $1.15M | $336.24K | $8.06M | $1.13M | $969.90K | 8.28× |
| 2014-12-31 | $11.74M | $1.84M | $455.84K | $9.26M | $2.02M | $905.12K | 6.37× |
| 2014-09-30 | $11.93M | $999.39K | $642.51K | $10.21M | $1.08M | $784.90K | 11.93× |
| 2014-06-30 | $12.89M | $971.55K | $402.28K | $11.44M | $1.05M | $752.60K | 13.27× |
| 2014-03-31 | $12.94M | $943.32K | $305.81K | $12.50M | $138.60K | $665.11K | 13.72× |
| 2013-12-31 | $222.04K | $1.65M | $103.63K | $0.00 | $118.40K | $1.03M | 0.13× |
| 2013-09-30 | (m) | (m) | $681.24K | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $1.55M | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | $521.50K | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $633.02K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |